Jane Chang
Impact in
-
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
-
- Bladder and Urothelial Cancer Treatments
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 10
- Economic and Financial Impacts of Cancer 3
- Surgery 15
- Bladder and Urothelial Cancer Treatments 15
- Co-authors
- Vivek S. Pawar (3 shared papers)Xinke Zhang (1 shared paper)Bhakti V. Arondekar (1 shared paper)Petros D. Grivas (4 shared papers)Jie Zhou (1 shared paper)Eric Nadler (1 shared paper)Kathleen M. Aguilar (1 shared paper)Po‐Jung Su (2 shared papers)
- Journals
- Future Oncology (7 papers)The Lancet Oncology (4 papers)Clinical Genitourinary Cancer (4 papers)Value in Health (4 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Jane Chang
36 papers receiving 277 citations
Peers
Comparison fields: 5 of 40
- Oncology 86
- Surgery 93
- Gastroenterology 15
- Economics and Econometrics 57
- Statistics and Probability 22
Countries citing papers authored by Jane Chang
This map shows the geographic impact of Jane Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Chang more than expected).
Fields of papers citing papers by Jane Chang
This network shows the impact of papers produced by Jane Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Chang. The network helps show where Jane Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 46 | |
| 2 | 2022 | 40 | |
| 3 | 2020 | 35 | |
| 4 | 2016 | 17 | |
| 5 | 2009 | 13 | |
| 6 | 2014 | 13 | |
| 7 | 2023 | 12 | |
| 8 | 2014 | 10 | |
| 9 | 2023 | 10 | |
| 10 | 2024 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2018 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2025 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2025 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 1999 | 3 | |
| 20 | 2017 | 3 |
About Jane Chang
Jane Chang is a scholar working on Economics and Econometrics, Surgery, Reproductive Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 286 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Prostate Cancer Treatment and Research (5 papers), Cancer survivorship and care (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Economic and Financial Impacts of Cancer (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Oncology (86 citations), Surgery (93 citations), Gastroenterology (15 citations), Economics and Econometrics (57 citations) and Statistics and Probability (22 citations). Jane Chang has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Vivek S. Pawar, Xinke Zhang, Bhakti V. Arondekar, Petros D. Grivas, Jie Zhou, Eric Nadler, Kathleen M. Aguilar, Po‐Jung Su, Thomas B. Powles and Claudia Caserta. Their work appears in journals such as Future Oncology, The Lancet Oncology, Clinical Genitourinary Cancer, Value in Health and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.